Kim J Y, Chung E J, Lee W Y, et al. Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson’s disease: analysis of11C-raclopride PET study[J]. Mov Disord, 2008, 23(2): 207-211.
[2]
Politis M, Piccini P, Pavese N,et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo11C-raclopride PET study[J]. Exp Neurol, 2008, 214(1): 112-116.
[3]
Langer O, Nagren K, Dolle F, et al. Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand C-11 raclopride from C-11 methyl triate[J]. J Labelled Compd Radiopharm,1999, 42: 1183-1193.
[4]
Zheng Q H, Mock B H. Puricfication of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE[J]. Biomed Chromatogr, 2005, 19, 671-676.
[5]
张锦明，田嘉禾，姚树林，等. 11C-Raclopride的快速制备及生物学分布[J]. 中华核医学杂志，2008，28（4）：227-230.Zhang Jinming, Tian Jiahe, Yao Shulin, et al. Fast synthesis of11C-Raclopride and its initial PET study on animal model[J].Chin J Nucl Med, 2008, 28(4):227-230(in Chinese).
[6]
李军，侯宁，李广义. 多巴胺D2受体正电子示踪剂11C-雷氯必利的自动化合成及质量控制[J]. 中国药学杂志，2007，42：706-708.Li Jun, Hou Ning, Li Guangyi. Automatic Synthesis and Quality control of11C-Raclopride Dopamine D2 receptor PET Radiotracer[J]. Chinese Pharm J, 2007, 42: 706-708(in Chinese).
[7]
Paulis T. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain[J].Cur Pharma Des, 2003, 9: 673-696
[8]
Kersemans K , Meestere D D, Goethals I ,et al. Improved HPLC puri cation strategy for11C-raclopride and11C-DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations[J]. Appl Radiat Isot, 2013, 78: 62-67.
[9]
张锦明,田嘉禾,王武尚,等. 在线制备11C-Triflate-CH3[J]. 同位素,2006,(02):124-128.Zhang Jinming, Tian Jiahe, Wang Wushang, et al. Preparation of11C-Triflate-CH3 on-line[J]. Journal of Isotopes, 2006, (2): 124-128(in Chinese).
[10]
Ishiwata K, Ishii S-I, Senda M. An alternative synthesis of11C-raclopride for routine use[J]. Ann Nuc Med,1999, 13: 195-197.
[11]
Wilson A A, Garcia A, Houle S, et al. Utility of commercial radiosynthestic modules in captive solvent11C-methylation reactions[J]. J Label Compd Radiopharm, 2009, 52: 490-492.
[12]
Iwata R, Pascalic A, Bognic A, et al. A simple loop method for the automated preparation of11C-raclopride from11C-methyl triflate[J]. Appl Radiat Isot, 2001, 55: 17-22.
[13]
Shao X ,Kilbourn MP.A simple modication of GE tracerlab FX C Pro for rapid sequential preparation of11C -carfentanil and11C -raclopride[J].Appl Radiat Isot, 2009, 67: 602-605.
[14]
Shao X, Schnau PL, Fawaz MV, et al. Enhanced radiosyntheses of11C-raclopride and11C-DASB using ethanolic loop chemistry[J]. Nucl Med Biol, 2013, 40: 109-116.
[15]
闫卫红，程焱，高硕，等. 轻型帕金森病D2受体的PET显像[J]. 中华神经外科杂志，2006，39：374-377.Yan Weihong, Cheng Yan, Gao Shuo, et al. PET image of D2 receptor in Parkinson. s disease[J].Chinese J Neurology, 2006, 39: 374-377(in Chinese).
[16]
王明芳,张锦明,唐刚华,等.11C-CH3-Triflate甲基化法合成11C-PK11195[J]. 同位素,2010,23(4):230-234.Wang Mingfang, Zhang Jinming, Tang Guanghua et al. Radiosynthesis of11C-PK11195 by Using [11C]Methyl Triflate[J]. Journal Of Isotopes, 2010, 23(4): 230-234(in Chinese).
[17]
Gomez-Vallejo V, Llop J. Fully automated and reproducible radiosynthesis of high specific activity11C-raclopride and11C-Pittsburgh compound-B using the combination of two commercial synthesizers[J]. Nucl Med Commun, 2011, 32: 1011-1017.
[18]
Iwata R, Ido T, Ujiie A , et al. Sugahara M. Comparative study of specic activity of [11C ] methyl iodide: a search for the source of carrier carbon Int.[J]. J Radiat Appl Instrum(A), 1988, 39 (1): 1-7.
[19]
Vanessa Go′mez-Vallejo, Jordi Llop. Specic activity of [11C]CH3I synthesized by the “wet” method: Main sources of non-radioactive carbon[J]. Appl Radiat Isot, 2009，67: 111-114.
[20]
[20 ] Ermert J, Stusgen S, Lang M, et al. High molar activity of [11C ]TCH346 via [11C ]methyl tri .ate using the “wet” [11C ]CO2 reduction method[J]. Appl Radiat Isot, 2008, 66: 619-624.
